336 pages, 8 colour illus
This book provides a timely and important discussion of the potential value of cloning and of the ethical choices that this radical new technology has raised, including the issues surrounding the current status of stem-cell research. As leader of the team that produced Dolly, the first animal to be cloned from an adult cell, Ian Wilmut has played a unique role both in the science of cloning and the ensuing international debate about its implications. He has testifed before parliamentary and congressional committees in the UK, France and the US and given many public lectures on the subject, in addtion to participating in numerous panel discussions on the uses of cloning.
This book distils the essence of the current scientific and social policy discussions around these critically important issues and presents them in an understandable manner so the educated reader can have an informed opinion.
'Chock-full of good science writing that provides an up-to-the-minute account of where we stand' THE TIMES 'Pacy and extremely clear. The scientific jargon is properly explained, and there is an excellent glossary' SCOTSMAN 'I so enjoyed this elegantly written inside story' NEW SCIENTIST '[Wilmut] is acutely aware of the controversies of his work and this is his attempt at communicating his side of things to the public - a responsible step to take and an enjoyable read into the bargain' MORNING STAR 'Whatever one's ethical views, the processes of reproductive biology and the emerging genetic technologies, need to be more widely understood. Here, a leader in his field, describes the nuts and bolts of his science in a language and style easily accessible to the lay reader.' SUNDAY BUSINESS POST 'AFTER DOLLY offers a fascinating insight into one of the most controversial yet promising areas of modern biology.' INDEPENDENT 'A highly readable account of a landmark in science.' FOCUS
There are currently no reviews for this product. Be the first to review this product!